Chromosome 3 translocations and the risk to develop renal cell cancer: A Dutch intergroup study

Genetic Counseling

Volumn 14, Issue 2, 2003, Pages 149-154

  Van Erp, F ^a   Van Ravenswaaij, C ^a   Bodmer, D ^a   Eleveld, M ^a   Hoogerbrugge, N ^a   Mulders, P ^a   Geurts Van Kessel, A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chromosome 3; Renal cell cancer; Translocations

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RISK; CHROMOSOME TRANSLOCATION 3; CLINICAL ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC APPROACH ROUTE; EARLY DIAGNOSIS; FAMILIAL CANCER; FEMALE; GENE SEGREGATION; GENETIC COUNSELING; GENETIC RISK; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; KIDNEY CARCINOMA; KIDNEY SURGERY; MALE; NETHERLANDS; RISK ASSESSMENT; VON HIPPEL LINDAU DISEASE;

CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIGASES; MALE; MIDDLE AGED; POINT MUTATION; RISK FACTORS; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0037668601     PISSN: 10158146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BODMER D., ELEVELD M., KATER-BAATS E., JANSSEN I., JANSSEN B., WETERMAN M., SCHOENMAKERS E., NICKERSON M., LINEHAN W.M., ZBAR B. and GEURTS VAN KESSEL A.: Disruption of a novel MFS transporter gene. DIRC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21). Hum. Mol. Genet., 2002, 11, 641-649.
2. BODMER D., ELEVELD M., LIGTENBERG M., WETERMAN M., JANSSEN B., SMEETS D., DE WIT P., VAN DEN BERG A., VAN DEN BERG E., KOOLEN M. and GEURTS VAN KESSEL A.: An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation. Am. J. Hum. Genet., 1998, 62, 1475-1483.
3. BODMER D., ELEVELD M., LIGTENBERG M., WETERMAN M., VAN DER MEIJDEN A., KOOLEN M., HULSBERGEN-VAN DER KAA C., SMEETS D. and GEURTS VAN KESSEL A.: Cytogenetic and molecular genetic analyses of early stage renal cell carcinomas in a family with a t(2;3)(q35;q21) chromosome translocation. Cancer Genet. Cytogenet., 2002, 134, 6-12.
4. COHEN A., LI F., BERG S., MARCHETTO D., TSAI S. and BROWN R.: Hereditary renal-cell carcinoma associated with a chromosomal translocation. N. Eng. J. Med., 1979, 301, 592-595.
5. ELEVELD M., BODMER D., MERKX G., SIEPMAN A., SPRENGER S., WETERMAN M., LIGTENBERG M., KAMP J., STAPPE W., JEUKEN W., SMEETS D., SMITS A. and GEURTS VAN KESSEL A.: Molecular analysis of a familial case of renal cell cancer and a t(3;6)(q21;q15). Genes Chrom. Cancer, 2001, 31, 23-32.
6. GEURTS VAN KESSEL A., WIJNHOVEN H., BODMER D., ELEVELD M., KIEMENEY L., MULDERS P., WETERMAN M., LIGTENBERG M., SMEETS D. and SMITS A.: Renal cell cancer: chromosome 3 translocations as risk factors. J. Natl. Cancer Inst., 1999, 91, 1159-1160.
7. GNARRA J.R., LERMAN M.I., ZBAR B. and LINEHAN W.M.: Genetics of renal cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin. Oncol., 1995, 22, 3-8.
8. KANAYAMA H., LUI W.O., TAKAHASHI M., NARODA T., KEDRA D., WONG F.K., KUROKI Y., NAKAHORI Y., LARSSON C., KAGAWA S. and THE B.T.: Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma. J. Med. Genet., 2000, 62, 1475-1483.
9. KNUDSON A.G.: Mutation and human cancer. Adv. Cancer Res., 1973, 17, 317-352.
10. KOOLEN M.I., VAN DER MEYDEN A.P.M., BODMER D., ELEVELD M., VAN DER LOOIJ E., BRUNNER H., SMITS A., VAN DEN BERG E., SMEETS D. and GEURTS VAN KESSEL A.: A familial case of renal cell carcinoma and a t(2;3) chromosome translocation. Kidney Int., 1998, 53, 273-275.
11. KOVACS G., BRUSA P. and DERIESE W.: Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal cell carcinomas. Int. J. Cancer, 1989, 43, 422-4227.
12. KOVACS G. and HOENE E.: Loss of der(3) in renal carcinoma cells of a patient with constitutional t(3;12). Hum. Genet., 1988, 78, 148-150.
13. MAHER E.R. and YATES J.R.W.: Familial renal cell carcinoma: clinical and molecular genetic aspects. Br. J. Cancer, 1991, 63, 176-179.
14. MOTZER R.J., BANDER N.H. and NANUS D.M.: Renal cell carcinoma. N. Eng. J. Med., 1996, 335, 865-875.
15. MULDERS P., FIGLIN R., DEKERNION J.B., WILTROUT R., LINEHAN M., PARKINSON D., DEWOLFF W. and BELLDEGRUN A.: Renal cell carcinoma: recent progress and future directions. Cancer Res. 1997, 57, 5189-5195.
16. TAKAHASHI M., KAHNOSKI R., GROSS D., NICOL D. and TEH B.T.: Familial adult renal neoplasia. J. Med. Genet., 2002, 39, 1-5.
17. VISSER O., COEBERGH J.W.W. and SCHOUTEN L.J.: Incidence of cancer in the Netherlands. Utrecht, Netherlands Cancer Registry, 1997.
18. WOODWARD E.R., CLIFFORD S.C., ASTUTI D., AFFARA N.A. and MAHER E.R.: Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes. J. Med. Genet., 2000, 37, 348-353.
19. ZAJACZEK S., GRONWALD J., KATA G., BOROWKA A. and LUBINSKI J.: Familial renal cell cancer (CRCC) associated with a constitutional reciprocal translocation t(2;3)(q33;q21). Cytogenet. Cell Genet., 1999, 85, 172.